Cytogenetic Changes in the Progression of Lymphoma

References

• Harris N.L., Jaffe E.S., Stein H., Banks P.M., Chan J.K.C., Cleary M.L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K.C., Grogan T.M., Isaacson P.G., Knowles D.M., Mason D.Y., Muller-Hermelink H-K., Piled S.A., Piris MA., Ralfkiaer E., Warnke R.A. A Revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• The Non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a Working Formulation for clinical usage. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• Bloomfield C.D., Arthur D.C., Frizzera G., Levine E.G., Peterson B.A., Gajl-Peczalska K.J. Nonrandom chromosome abnormalities in lymphoma. Cancer Research 1983; 43: 2975–2984
   PubMed Web of Science ®Google Scholar
• Kaneko Y., Rowley J.D., Variakojis D., Haren J.M., Ueshima Y., Daly K., Kluskens L.F. Prognostic implications of karyotype and morphology in patients with non-Hodgkin's lymphoma. International Journal of Cancer 1983; 32: 683–692
   PubMed Web of Science ®Google Scholar
• Yunis J.J., Oken M.M., Theologides A., Howe R.B., Kaplan M.E. Recurrent chromosomal defects are found in most patients with non-Hodgkin's lymphoma. Cancer Genetics and Cytogenetics 1984; 13: 17–28
   PubMed Web of Science ®Google Scholar
• Levine E.G., Arthur D.C., Frizzeria G., Peterson B.A., Hurd D.D., Bloomfield C.D. There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphomas. Blood 1985; 66: 1414–1422
   PubMed Web of Science ®Google Scholar
• Levine E.G., Arthur D.C., Gajl-Peczalska K.J., LeBien T.W., Peterson B.A., Hurd D.D., Bloomfield C.D. Correlations between immunological phenotype and karyotype in malignant lymphoma. Cancer Research 1986; 46: 6481–6488
   PubMed Web of Science ®Google Scholar
• Fifth International Workshop on Chromosomes in Leukemia-Lymphoma. Correlation of chromosome abnormalities with histologic and immunologic characteristics in non-Hodgkin's lymphoma and adult T-cell leukemia-lymphoma. Blood 1987; 70: 1554–1564
   PubMed Web of Science ®Google Scholar
• Koduru P.R.K., Filippa D.A., Richardson M.E., Jhanwar S.C., Chaganti S.R., Koziner B., Clarkson B.D., Lieberman P.H., Chaganti R.S.K. Cytogenetic and histologic correlations in malignant lymphoma. Blood 1987; 69: 97–102
   PubMed Web of Science ®Google Scholar
• Kristoffersson U., Heim S., Mandahl N., Olsson H., Ranstam J., Åkerman M., Mitelman F. Prognostic implication of cytogenetic findings in 106 patients with Non-Hodgkin Lymphoma. Cancer Genetics and Cytogenetics 1987; 25: 55–64
   PubMed Web of Science ®Google Scholar
• Richardson M.E., Quanguang C., Filippa D.A., Offit K., Hampton A., Koduru P.R.K., Jhanwar S.C., Lieberman P.H., Clarkson B.D., Chaganti R.S.K. Intermediate-to high-grade histology of lymphomas carrying t(14;18) is associated with additional nonrandom chromosomes changes. Blood 1987; 70: 444–447
   PubMed Web of Science ®Google Scholar
• Yunis J.J., Frizzera G., Oken M.M., McKenna J., Theologides A., Arnesen M. Multiple recurrent genomic defects in follicular lymphoma. The New England Journal of Medicine 1987; 316: 79–84
   PubMed Web of Science ®Google Scholar
• Levine E.G., Arthur D.C., Frizzera G., Peterson B.A., Hurd D.D., Bloomfield C.D. Cytogenetic abnormalities predict clinical outcome in non-Hodgkin lymphoma. Annals of Internal Medicine 1988; 108: 14–20
   PubMed Web of Science ®Google Scholar
• Armitage J.O., Sanger W.G., Weisenburger D.D., Harrington D.S., Linder J., Bierman P.J., Vose J.M., Purtilo D.T. Correlation of secondary cytogenetic abnormalities with histologic appearance in non-Hodgkin's lymphomas bearing t(14;18)(q32;21). Journal of the National Cancer Institute 1988; 80: 576–580
   PubMed Web of Science ®Google Scholar
• Cabanillas F., Pathak S., Grant G., Hagemeister F.B., McLaughlin P., Swan F., Rodriguez M.A., Trujillo J., Cork A., Butler J.J., Katz R., Bourne S., Freireich E.J. Refractoriness to chemotherapy and poor survival related to abnormalities of chromosomes 17 and 7 in lymphoma. The American Journal of Medicine 1989; 87: 167–172
   PubMed Web of Science ®Google Scholar
• Juneja S., Lukeis R., Tan L., Cooper I., Szelag G., Parkin J.D., Ironside P., Garson O.M. Cytogenetic analysis of 147 cases of non-Hodgkin's lymphoma: non-random chromosomal abnormalities and histological correlations. British Journal of Haematology 1990; 76: 231–237
   PubMed Web of Science ®Google Scholar
• Schouten H.C., Sanger W.G., Weisenburger D.D., Anderson J., Armitage J.O. Chromosomal abnormalities in untreated patients with non-Hodgkin's lymphoma: Associations with histology, clinical characteristics, and treatment outcome. Blood 1990; 75: 1841–1847
   PubMed Web of Science ®Google Scholar
• Offit K., Jhanwar S.C., Ladanyi M., Filippa D.A., Chaganti R.S.K. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment. Genes, Chromosomes & Cancer 1991; 3: 189–201
   PubMed Web of Science ®Google Scholar
• Offit K., Wong G., Filippa D.A., Tao Y., Chaganti R.S.K. Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: Clinical correlations. Blood 1991; 77: 1508–1515
   PubMed Web of Science ®Google Scholar
• Clark H.M., Jones D.B., Wright D.H. Cytogenetic and molecular studies of t(14;18) and t(14;19) in nodal and extranodal B-cell lymphoma. Journal of Pathology 1992; 166: 129–137
   PubMed Web of Science ®Google Scholar
• Hammond D.W., Goepel J.R., Aitken M., Hancock B.W., Potter A.M., Goyns M.H. Cytogenetic analysis of a United Kingdom series of non-Hodgkin's lymphomas. Cancer Genetics and Cytogenetics 1992; 61: 31–38
   PubMed Web of Science ®Google Scholar
• Whang-Peng J., Knutsen T., Jaffe E.S., Steinberg S.M., Raffeld M., Zhao W.P., Duffey P., Condron K., Yano T., Longo D.L. Sequential analysis of 43 patients with non-Hodgkin's lymphoma: Clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies. Blood 1995; 85: 203–216
   PubMed Web of Science ®Google Scholar
• Johansson B., Mertens F., Mitelman F. Cytogenetic evolution patterns in non-Hodgkin's lymphoma. Blood 1995; 86: 3905–3914
   PubMed Web of Science ®Google Scholar
• Catalog of Chromosome Aberrations in Cancer, 5th ed., F. Mitelman, B. Johansson, F. Mertens. Wiley-Liss, New York 1994; 4252
   Google Scholar
• Magrath I.T. Introduction: concepts and controversies in lymphoid neoplasia. The Non-Hodgkin's Lymphomas, 2nd ed., I.T. Magrath. Arnold, London 1997; 3–46
   Google Scholar
• Whang-Peng J., Bunn P.A., Jr., Knutsen T., Matthews M.J., Schechter G., Minna J.D. Clinical implications of cytogenetic studies in cutaneous T-cell lymphoma (CTCL). Cancer 1982; 50: 1539–1553
   PubMed Web of Science ®Google Scholar
• Vonderheid E.C., Sobel E.L., Nowell P.C., Finan J.B., Helfrich M.K., Whipple D.S. Diagnostic and prognostic significance of Sézary cells in peripheral blood smears from patients with cutaneous T-cell lymphoma. Blood 1985; 66: 358–366
   PubMed Web of Science ®Google Scholar
• Sanada I., Tanaka R., Kumagai E., Tsuda H., Nishimura H., Yamaguchi K., Kawano F., Fujiwara H., Takatsuki K. Chromosomal aberrations in adult T-cell leukemia: Relationship to the clinical severity. Blood 1985; 65: 649–654
   PubMed Web of Science ®Google Scholar
• Whang-Peng J., Bunn P.A., Knutsen T., Kao-Shan C.S., Broder S., Jaffe E.S., Gelmann E., Blattner W., Lofters W., Young R.C., Gallo R.C. Cytogenetic studies in human T-cell lymphoma virus (HTLV)-positive leukemia-lymphoma in the United States. Journal of the National Cancer Institute 1985; 74: 357–369
   PubMed Web of Science ®Google Scholar
• Pandolfi F. T-CLL and allied diseases: New insights into classification and pathogenesis. Diagnostic Immunology 1986; 4: 61–74
   PubMedGoogle Scholar
• Schlegelberger B., Himmler A., Bartles H., Kuse R., Sterry W., Grote W. Recurrent chromosome abnormalities in peripheral T-cell lymphomas. Cancer Genetics and Cytogenetics 1994; 78: 15–22
   PubMed Web of Science ®Google Scholar
• Schlegelberger B., Himmler A., Gödde E., Grote W., Feller A.C., Lennert K. Cytogenetics findings in peripheral T-cell lymphomas as a basis for distinguishing low-grade and high-grade lymphomas. Blood 1994; 83: 505–511
   PubMed Web of Science ®Google Scholar
• Mecucci C., Michaux J.-L., Tricot G., Louwagie A., van den Berghe H. Rearrangements of the short arm of chromosome no. 6 in T-cell lymphomas. Leukemia Research 1985; 9: 1139–1148
   PubMed Web of Science ®Google Scholar
• Offit K., Parsa N.Z., Gaidano G., Filippa D.A., Louie D., Pan D., Jhanwar S.C., Dalla-Favera R., Chaganti R.S.K. 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma. Blood 1993; 82: 2157–2162
   PubMed Web of Science ®Google Scholar
• Heim S., Mitelman F. Malignant lymphomas. Cancer Cytogenetics, 2nd ed. Wiley-Liss, New York 1995; 266–309
   Google Scholar
• Limon J., Nedoszytho B., Brozek I., Hellmann A., Zajaczek S., Lubinski J., Mrozek K. Chromosome aberrations, spontaneous SCE, and growth kinetics in PHA-stimulated lymphocytes of five cases with Sezary syndrome. Cancer Genetics and Cytogenetics 1995; 83: 75–81
   PubMed Web of Science ®Google Scholar
• Schlegelberger B., Zhang Y., Weber-Matthiesen K., Grote W. Detection of aberrant clones in nearly all cases of angioimmunoblastic lymphadenopathy with dyspro-teinemia-type T-cell lymphoma by combined interphase and metaphase cytogenetics. Blood 1994; 84: 2640–2648
   PubMed Web of Science ®Google Scholar
• Kaneko Y., Larson R.A., Variakojis D., Haren J.M., Rowley J.D. Nonrandom chromosome abnormalities in angioimmunoblastic lymphadenopathy. Blood 1982; 60: 877–887
   PubMed Web of Science ®Google Scholar
• Kaneko Y., Maseki N., Sakurai M., Takayama S., Nanba K., Kikuchi M., Frizzera G. Characteristic kary-otypic pattern in T-cell lymphoproliferative disorders with reactive “angioimmunoblastic lymphadenopathy with dysproteinemia-type” features. Blood 1988; 72: 413–421
   PubMed Web of Science ®Google Scholar
• Gödde-Salz E., Feller A.C., Lennert K. Chromosomal abnormalities in lymphogranulomatosis X (LgrX)/angioimmunoblastic lymphadenopathy (AILD). Leukemia Research 1987; 11: 181–190
   PubMed Web of Science ®Google Scholar
• Schlegelberger B., Feller A., Gödde E., Grote W., Lennert K. Stepwise development of chromosomal abnormalities in angioimmunoblastic lymphadenopathy. Cancer Genetics and Cytogenetics 1990; 50: 15–29
   PubMed Web of Science ®Google Scholar
• Schlegelberger B., Zwingers T., Hohenadel K., Henne-Bruns D., Schmitz N., Haferlach T., Tirier C., Bartels H., Sonnen R., Kuse R., Grote W. Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Journal of Clinical Oncology 1996; 14: 593–599
   PubMed Web of Science ®Google Scholar
• Heim S., Mitelman F. Cytogenetically unrelated clones in hematological neoplasms. Leukemia 1989; 3: 6–8
   PubMed Web of Science ®Google Scholar
• Schwab U., Stein H., Gerdes J., Lemke H., Kirchner H., Schaadt M., Diehl V. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 1982; 299: 65–67
   PubMed Web of Science ®Google Scholar
• Stein H., Mason D.Y., Gerdes J., O'Connor N., Wainscoat J., Pallesen G., Gatter K., Falini B., Delsol G., Lemke H., Schwarting R., Lennert K. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985; 66: 848–858
   PubMed Web of Science ®Google Scholar
• Morgan R., Hecht B.K., Sandberg A.A., Hecht F., Smith S.D. Chromosome 5q35 breakpoint in malignant histiocytosis. The New England Journal of Medicine 1986; 314: 1322
   PubMed Web of Science ®Google Scholar
• Ebrahim S.A.D., Ladanyi M., Desai S.B., Offit K., Jhanwar S.C., Filippa D.A., Lieberman P.H., Chaganti R.S.K. Immunohistochemical, molecular, and cytogenetic analysis of a consecutive series of 20 peripheral T-cell lymphomas and lymphomas of uncertain lineage, including 12 Ki-1 positive lymphomas. Genes, Chromosomes & Cancer 1990; 2: 27–35
   PubMed Web of Science ®Google Scholar
• Morris S.W., Kirstein M.N., Valentine M.B., Dittmer K.G., Shapiro D.N., Saltman D.L., Look T.A. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994; 263: 1281–1284
   PubMed Web of Science ®Google Scholar
• Bitter M.A., Franklin W.A., Larson R.A., McKeithan T.W., Rubin C.M., LeBeau M.M., Stephens J.K., Vardiman J.W. Morphology in Ki-1 (CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). The American Journal of Surgical Pathology 1990; 14: 305–316
   PubMed Web of Science ®Google Scholar
• Kadin M.E., Kinney M.C. Pathogenesis of Ki-1+ lymphomas. The Non-Hodgkin 's Lymphomas, 2nd ed., I. Magrath. Arnold, London 1997; 443–458
   Google Scholar
• Kaneko Y., Variakojis D., Kluskens L., Rowley J.D. Lymphoblastic lymphoma: Cytogenetic, pathologic, and immunologic studies. International Journal of Cancer 1982; 30: 273–279
   PubMed Web of Science ®Google Scholar
• Arenson E., Pasut B., Cartens B., McGavran L. Translocation (2;9) associated with poor outcome of childhood lymphoblastic lymphoma. Proceedings of the American Society of Clinical Oncology 1989; 8: 1091, Abstract
   Google Scholar
• Colwill R., Dubé I., Scott J.G., Bailey D., Deharven E., Carstairs K., Pantolony D. Isochromosome 7q as the sole abnormality in an unusual case of T-cell lineage malignancy. Hematologic Pathology 1990; 4: 53–58
   PubMedGoogle Scholar
• Wang C.-C, Tien H.-F., Lin M.-T., Su I.-J., Wang C.-H., Chuang S.-M., Shen M.-C., Liu C.-H. Consistent presence of isochromosome 7q in hepatosplenic T γ/δ lymphoma: A new cytogenetic-clinicopathologic entity. Genes, Chromosomes & Cancer 1995; 12: 161–164
   PubMed Web of Science ®Google Scholar
• Zelenetz A.D., Brodeur D. Pathogenesis of the low-grade B-cell lymphomas. The Non-Hodgkin's Lymphomas, 2nd ed., I.T. Magrath. Arnold, London 1997; 353–375
   Google Scholar
• Offit K., Louie D.C., Parsa N.Z., Filippa D., Gangi M., Siebert R., Chaganti R.S.K. Clinical and morphologic features of B-cell small lymphocytic lymphoma with del(6)(q21q23). Blood 1994; 83: 2611–2618
   PubMed Web of Science ®Google Scholar
• Evans H.L., Butler J.J., Youness E.L. Malignant lymphoma, small lymphocytic type: A clinico-pathologic study of 84 cases with suggested criteria for intermediate lymphocytic lymphoma. Cancer 1978; 41: 1440–1455
   PubMed Web of Science ®Google Scholar
• Offit K., Parsa N.Z., Filippa D., Jhanwar S.C., Chaganti R.S.K. t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation. Blood 1992; 80: 2594–2599
   PubMed Web of Science ®Google Scholar
• Iida S., Rao P.H., Nallasivam P., Hibshoosh H., Butler M., Louie D.C., Dyomin V., Ohno H., Chaganti R.S.K., Dalla-Favera R. The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. Blood 1996; 88: 4110–4117
   PubMed Web of Science ®Google Scholar
• Offit K., Louie D.C., Parsa N.Z., Noy A., Chaganti R.S.K. Del(7)(q32) is associated with a subset of small lymphocytic lymphoma with plasmacytoid features. Blood 1995; 86: 2365–2370
   PubMed Web of Science ®Google Scholar
• Whang-Peng J., Knutsen T., Jaffe E., Raffeld M., Zhao W.P., Duffey P., Longo D.L. Cytogenetic study of two cases with lymphoma of mucosa-associated lymphoid tissue. Cancer Genetics and Cytogenetics 1994; 77: 74–80
   PubMed Web of Science ®Google Scholar
• Wotherspoon A.C., Finn T.M., Isaacson P.G. Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. Blood 1995; 85: 2000–2004
   PubMed Web of Science ®Google Scholar
• Brynes R.K., Almaguer P.D., Leathery K.E., McCourty A., Arber D.A., Medeiros L.J., Nathwani B.N. Numerical cytogenetic abnormalities of chromosomes 3, 7, and 12 in marginal zone B-cell lymphomas. Modern Pathology 1996; 9: 995–1000
   PubMed Web of Science ®Google Scholar
• Dierlamm J., Michauz L., Wlodarska I., Pittaluga S., Zeller W., Stul M., Crie A., Thomas J., Boogaerts M., Delaere P., Cassiman J.-J., De Wolf-Peeters C., Mecucci C., Van den Berghe H. Trisomy 3 in marginal zone B-cell lymphoma: a study based on cytognetic analysis and fluorescence in situ hybridization. British Journal of Haematology 1996; 93: 242–249
   PubMed Web of Science ®Google Scholar
• Van Krieken J. H. J. M., Raffeld M., Raghoebier S., Jaffe E.S., van Ommen G.J.B., Kluin Ph.M. Molecular genetics of gastrointestinal non-Hodgkin's lymphomas: Unusual prevalence and pattern of c-myc rearrangements in aggressive lymphomas. Blood 1990; 76: 797–800
   PubMed Web of Science ®Google Scholar
• Okuda A., Suzuki H. Effects of DNA ploidy patterns on the survival of patients with primary gastrointestinal lymphoma. Surgery Today (Japanese Journal of Surgery) 1996; 8: 586–590
   Google Scholar
• Levine E.G., Arthur D.C., Machnicki J., Frizzera G., Hurd D., Peterson B., Gajl-Peczalska K.J., Bloomfield C.D. Four new recurring translocations in non-Hodgkin's lymphoma. Blood 1989; 74: 1796–1800
   PubMed Web of Science ®Google Scholar
• Horsman D., Gascoyne R., Klasa R., Coupland R. t(11;18)(q21;q21.1): A recurring translocation in lymphomas of mucosa-associated lymphoid tissue (MALT)?. Genes, Chromosomes & Cancer 1992; 4: 183–187
   PubMed Web of Science ®Google Scholar
• Fukuhara S., Rowley J.D., Variakojis D., Golomb H. Chromosome abnormalities in poorly differentiated lymphocytic lymphoma. Cancer Research 1979; 39: 3119–3128
   PubMed Web of Science ®Google Scholar
• Bakhshi A., Jensen J.P., Goldman P., Wright J.J., McBride O.W., Epstein A.L., Korsmeyer S.J. Cloning the chromosomal breakpoint of t(14;18) human lymphomas: Clustering around JH on chromosome 14 and near a transcriptional unit on chromosome 18. Cell 1985; 41: 899–906
   PubMed Web of Science ®Google Scholar
• Hockenbury D., Nuñez G., Milliman C., Schreiber R.D., Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334–336
   PubMed Web of Science ®Google Scholar
• Yarkoni S., Lishner M., Tangi I., Nagler A., Lorberboum-Galski H. B-cell non-Hodgkin's lymphoma: evidence for the (14;18) translocation in all hematopoietic cell lineages. Journal of the National Cancer Institute 1996; 88: 973–979
   PubMed Web of Science ®Google Scholar
• Limpens J., de Jong D., van Krieken J. H. J. M., Price G.G.A., Young B.D., van Ommen G.-J. B., Kluin P.M. Bc/-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 1991; 6: 2271–2276
   PubMed Web of Science ®Google Scholar
• Liu Y., Hernandez A.M., Shibata D., Cortopassi G.A. BCL2 translocation frequency rises with age in humans. Proceedings of the National Academy of Sciences USA 1994; 91: 8910–8914
   PubMed Web of Science ®Google Scholar
• Whang-Peng J., Lee E.C. Cytogenetics. The Non-Hodgkin's Lymphomas, I. Magrath. Edward Arnold, London 1990; 77–95
   Google Scholar
• Offit K. Chromosome analysis in the management of patients with Non-Hodgkin's lymphoma. Leukemia & Lymphoma 1992; 1: 275–282
   Web of Science ®Google Scholar
• Tilly H., Rossi A., Stamatoullas A., Lenormand B., Bigorgne C., Kunlin A., Monconduit M., Bastard C. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 1994; 84: 1043–1049
   PubMed Web of Science ®Google Scholar
• Sardas S., Erdogan F., Sardas O.S., Cengel M., Karakaya A.E. Sister chromatid exchange studies for monitoring DNA damage in lymphocytes of malignant lymphoma patients under cytostatic therapy. Anti-cancer Drugs 1994; 5: 487–489
   PubMed Web of Science ®Google Scholar
• Karsan A., Gascoyne R.D., Coupland R.W., Shepherd J.D., Phillips G.L., Horsman D.E. Combination of t(14;18) and a Burkitt's type translocation in B-cell malignancies. Leukemia and Lymphoma 1993; 10: 433–441
   PubMed Web of Science ®Google Scholar
• Yano T., Jaffe E.S., Longo D.L., Raffeld M. MYC rearrangements in histologically progressed follicular lymphomas. Blood 1992; 80: 758–767
   PubMed Web of Science ®Google Scholar
• Ladanyi M., Offit K., Parsa N.Z., Condon M.R., Chekka N., Murphy J.P., Filippa D.A., Jhanwar S.C., Dalla-Favera R., Chaganti R.S.K. Follicular lymphoma with t(8;14)(q24;q32): A distinct clinical and molecular subset of t(8;14)-bearing lymphomas. Blood 1992; 79: 2124–2130
   PubMed Web of Science ®Google Scholar
• Bastard C., Deweindt C., Kerckaert J.P., Lenormand B., Rossi A., Pezzella F., Fruchart C., Duval C., Monconduit M., Tilly H. LAXi Rearrangements in non-Hodgkin's lymphoma: Correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood 1994; 83: 2423–2427
   PubMed Web of Science ®Google Scholar
• Horsman D.E., McNeil B.K., Anderson M., Shenkier T., Gascoyne R.D. Frequent association of t(3;14) or variant with other lymphoma-specific translocations. British Journal of Haematology 1995; 89: 569–575
   PubMed Web of Science ®Google Scholar
• Otsuki T., Yano T., Clark H.M., Bastard C., Kerchaert J.P., Jaffe E.S., Raffeld M. Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: Results of rearrangement and gene expression studies and a mutational analysis of coding region sequences. Blood 1995; 85: 2877–2884
   PubMed Web of Science ®Google Scholar
• Deweindt C., Kerckaert J.-P., Tilly H., Quief S., Nguyen V.C., Bastard C. Cloning of a breakpoint cluster region at band 3q27 involved in human non-Hodgkin's lymphoma. Genes, Chromosomes & Cancer 1993; 8: 149–154
   PubMed Web of Science ®Google Scholar
• Offit K., Richardson M.E., Quanguang C., Hampton A., Koduru P.R.K., Jhanwar S.C., Filippa D.A., Lieberman P.H., Clarkson B., Chaganti R.S.K. Nonrandom chromosomal aberrations are associated with sites of tissue involvement in non-Hodgkin's lymphoma. Cancer Genetics and Cytogenentics 1989; 37: 85–93
   PubMed Web of Science ®Google Scholar
• Schouten H.C., Sanger W.G., Weisenburger D.D., Armitage J.O. Abnormalities involving chromosome 6 in newly diagnosed patients with non-Hodgkin's lymphoma. Cancer Genetics and Cytogenetics 1990; 47: 73–82
   PubMed Web of Science ®Google Scholar
• Lo Coco F., Gaidano G., Louie D.C., Offit K., Chaganti R.S.K., Dalla-Favera R. p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 1993; 82: 2289–2295
   PubMed Web of Science ®Google Scholar
• Sander C.A., Yano T., Clark H.M., Harris C., Longo D.L., Jaffe E.S., Raffeld M. p53 Mutation is associated with progression in follicular lymphomas. Blood 1993; 82: 1994–2004
   PubMed Web of Science ®Google Scholar
• Fukuhara S., Ohno H., Amakawa R., Edamura S., Tomono N., Nasu K., Doi S., Yamabe H., Abe M., Wakasa H., Uchino H. Significance of extra 18q-chromosome in Japanese t(14;18)-positive lymphoma. Blood 1988; 71: 1748–1751
   PubMed Web of Science ®Google Scholar
• Sandberg A.A. The Chromosomes in Human Cancer and Leukemia, 2nd ed. Elsevier, New York 1990
   Google Scholar
• Younes A., Pugh W., Goodacre A., Katz R., Rodriguez M.A., Hill D., Cabanillas F., Andreeff M. Polysomy of chromosomes 12 in 60 patients with non-Hodgkin's lymphoma assessed by fluorescence in situ hybridization: Differences between follicular and diffuse large cell lymphoma. Genes, Chromosomes & Cancer 1994; 9: 161–167
   PubMed Web of Science ®Google Scholar
• Younes A., Jendiroba D., Engel H., Escudier S., Katz R., Rodriguez M.A., Hill D., Cabanillas R., Andreeff M. High incidence of monosomy 18 in lymphoid malignancies that have bone marrow and peripheral blood involvement. Cancer Genetics and Cytogenetics 1994; 77: 39–44
   PubMed Web of Science ®Google Scholar
• Younes A., Jendiroba D., Katz R., Hill D., Cabanillas F., Andreeff M. Chromosome X numerical abnormalities in patients with non-Hodgkin's lymphoma. A study of 59 patients using fluorescence in situ hybridization. Cancer Genetics and Cytogenetics 1995; 82: 23–29
   PubMed Web of Science ®Google Scholar
• Raffeld M., Jaffe E.S. bcl-1, t(11;14), and mantle cell-derived lymphomas. Blood 1991; 78: 259–263
   PubMed Web of Science ®Google Scholar
• Van den Berghe H., Parloir C., David G., Michaux J.L., Sokal G. A new characteristic karyotypic anomaly in lymphoproliferative disorders. Cancer 1979; 44: 188–195
   PubMed Web of Science ®Google Scholar
• Vandenberghe E., De Wolfe Peeters C., Wlodarska I., Stul M., Louwagie A., Verhoef G., Thomas J., Criel A., Cassiman J.J., Mecucci C., Van den Berghe H. Chromosome 11q rearrangements in B non Hodgkin's lymphoma. British Journal of Haematology 1992; 81: 212–217
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y., Jaffe E., Cossman J., Gorham J., Nowell P.C., Croce C.M. Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(11;14) chromosome translocation. Nature 1985; 315: 340–345
   PubMed Web of Science ®Google Scholar
• Rosenberg C.L., Wong E., Petty E.M., Bale A.E., Tsujimoto Y., Harris N.L., Arnold A. PRAD1, a candidate BCLI oncogene: Mapping and expression in centrocytic lymphoma. Proceedings of the National Academy of Sciences USA 1991; 88: 9638–9642
   PubMed Web of Science ®Google Scholar
• Leroux D., Monteil M. Diagnosis of t(11;14)(q13;q32) using interaphse fluorescent in situ hybridization. Blood 1994; 84: 608a, abstract
   PubMed Web of Science ®Google Scholar
• Vaandrager J-W., Schuuring E., Zwikstra E., de Boer C.J., Kleiverda K.K., van Krieken J. H. J. M., Kluin-Nelemans H.C., van Ommen G-J., Raap A.K., Kluin P.M. Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridiation. Blood 1996; 88: 1177–1182
   PubMed Web of Science ®Google Scholar
• Leroux D., Le Marc'Hadour F., Gresin R., Jacob M-C., Keddari E., Monteil M., Caillot P., Jalbert P., Sotto J.J. Non-Hodgkin's lymphomas with t(11;14)(q13; q32): a subset of mantle zone/intermediate lymphocytic lymphoma?. British Journal of Haematology 1991; 77: 346–353
   PubMed Web of Science ®Google Scholar
• Hernandez L., Fest T., Cazorla M., Teruya-Feldstein J., Bosch F., Peinado M.A., Piris M.A., Montserrat E., Cardesa A., Jaffe E.S., Campo E., Raffeld M. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood 1996; 87: 3351–3359
   PubMed Web of Science ®Google Scholar
• Louie D.C., Offit K., Jaslow R., Parsa N.Z., Murty V. V. V. S., Schluger A., Chaganti R.S.K. p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). Blood 1995; 86: 2892–2899
   PubMed Web of Science ®Google Scholar
• Magrath I. The non-Hodgkin's lymphomas: An introduction. The Non-Hodgkin 's Lymphomas, I. Magrath. Edward Arnold, London 1990; 1–14
   Google Scholar
• Longo D.L., Duffey P.L., DeVita V.T., Wiernik P.H., Hubbard S.M., Phares J.C., Bastian A.W., Jaffe E.S., Young R.C. Treatment of advanced-stage Hodgkin's disease: Alternating non-crossresistant MOPP/CABS is not superior to MOPP. Journal of Clinical Oncology 1991; 9: 1409–1420
   PubMed Web of Science ®Google Scholar
• Gaynor E.R., Fisher R.I. Diffuse aggressive lymphomas in adults. The Non-Hodgkin's Lymphomas, 2nd ed., I. Magrath. Edward Arnold, London 1997; 897–906
   Google Scholar
• Yunis J.J., Mayer M.G., Arnesen M.A., Aeppli D.P., Oken M.M., Frizzera G. bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma. New England Journal of Medicine 1989; 320: 1047–1054
   PubMed Web of Science ®Google Scholar
• Chang C-C., Ye B.H., Chaganti R.S.K., Dalla-Favera R. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proceedings of the National Academy of Sciences USA 1996; 93: 6947–6952
   PubMed Web of Science ®Google Scholar
• Lo Coco F., Ye B.H., Lista F., Corradini P., Offit K., Knowles D.M., Chaganti R.S.K., Dalla-Favera R. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood 1994; 83: 1757–1759
   PubMed Web of Science ®Google Scholar
• Offit K., Lo Coco F., Louie D.C., Parsa N.Z., Leung D., Portlock C., Ye B.H., Lista F., Filippa D.A., Rosenbaum A., Ladanyi M., Jhanwar S., Dalla-Favera R., Chaganti R.S.K. Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma. The New England Journal of Medicine 1994; 331: 74–80
   PubMed Web of Science ®Google Scholar
• Offit K., Koduru P.R.K., Hollis R., Filippa D., Jhanwar S.C., Clarkson B.C., Chaganti R.S.K. 18q21 Rearrangement in diffuse large cell lymphoma: incidence and clinical significance. British Journal of Haematology 1989; 72: 178–183
   PubMed Web of Science ®Google Scholar
• Jacobson J.O., Wilkes B.M., Kwiatkowski D.J., Medeiros L.J., Aisenberg A.C., Harris N.L. bcl-2 rearrangements in de novo diffuse large cell lymphoma. Cancer 1993; 72: 231–236
   PubMed Web of Science ®Google Scholar
• Miller T.P., Lippman S.M., Spier C.M., Slymen D.J., Grogan T.M. HLA-DR (1a) immune phenotype predicts outcome for patients with diffuse large cell lymphoma. Journal of Clinical Investigation 1988; 82: 370–372
   PubMed Web of Science ®Google Scholar
• Lukeis R., Juneja S., Tan L., Matthews J., Cooper I., Ironside P., Garson O.M. Association of abnormalities of chromosome 11 with t(14;18) in diffuse non-Hodgkin's lymphoma. Cancer Genetics and Cytogenetics 1994; 78: 36–39
   PubMed Web of Science ®Google Scholar
• Houldsworth J., Mathew S., Rao P.H., Dyomina K., Louie D.C., Parsa N., Offit K., Chaganti R.S. REL proto-oncogene is frequently amplified in extranodal diffuse large cell lymphoma. Blood 1996; 87: 25–29
   PubMed Web of Science ®Google Scholar
• Joos S., Otaño-Joos M.I., Ziegler S., Brüderlein du Manoir S., Bentz M., Möller P., Lichter P. Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 1996; 87: 1571–1578
   PubMed Web of Science ®Google Scholar
• Offit K., Parsa N.Z., Jhanwar S.C., Filippa D., Wachtel M., Chaganti R.S.K. Clusters of chromosome 9 aberrations are associated with clinico-pathologic subsets of non-Hodgkin's lymphoma. Genes, Chromosomes & Cancer 1993; 7: 1–7
   PubMed Web of Science ®Google Scholar
• Chaganti S.R., Gaidano G., Louie D.C., Dalla-Favera R., Chaganti R.S.K. Diffuse large cell lymphomas exhibit frequent deletions in 9p21-22 and 9q31-34 regions. Genes, Chromosomes & Cancer 1995; 12: 32–36
   PubMed Web of Science ®Google Scholar
• Monni O., Joensuu H., Franssila K., Knuutila S. DNA copy number changes in diffuse large B-cell lymphoma—comparative genomic hybridization study. Blood 1996; 87: 5269–5278
   PubMed Web of Science ®Google Scholar
• Berger R., Bernheim A. Cytogenetics of Burkitt's lymphoma-leukaemia: A review. IARC Science Publications 1985; 60: 65–80
   PubMedGoogle Scholar
• Kornblau S.M., Goodacre A., Cabanillas F. Chromosomal abnormalities in adult non-endemic Burkitt's lymphoma and leukemia: 22 new reports and a review of 148 cases from the literature. Hematological Oncology 1991; 9: 63–78
   PubMed Web of Science ®Google Scholar
• Gaidano G., Ballerini P., Gong J.Z., Inghirami G., Neri A., Newcomb E.W., Magrath I.T., Knowles D.M., Dalla-Favera R. p53 mutations in human lymhoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proceedings of the National Acadamy of Sciences USA 1991; 88: 5413–5417
   PubMed Web of Science ®Google Scholar
• Bhatia K.G., Gutiérrez M., Huppi K., Siwarski D., Magath I.T. The spectrum of p53 mutations in Burkitt's lymphoma differs from that in solid tumors. Cancer Research 1992; 52: 1–4
   PubMedGoogle Scholar
• Heim S., Mitelman F. Malignant lymphomas. Cancer Cytogenetics. Alan R. Liss, New York 1987; 210–225
   Google Scholar
• Garry V.F., Tarone R.E., Long L., Griffith J., Kelly J.T., Burroughs B. Pesticide appliers with mixed pesticide exposure: G-banded analysis and possible relationship to non-Hodgkin's lymphoma. Cancer Epidemiology, Biomarkers & Prevention 1996; 5: 11–16
   PubMed Web of Science ®Google Scholar